Why India rejected a patent application for shorter drug-resistant TB treatment | Explained
Esta noticia se compara en 2 medios: ver la comparativa →
The decision could open the door to greater generic competition, but its impact on treatment costs will depend on drug availability, pricing, and access to care
Ficha de captura
- Fuente
- https://www.thehindu.com/sci-tech/health/why-india-rejected-a-patent-application-for-shorter-drug-resistant-tb-treatment-explained/article71639506.ece
- Publicado
- 29/10/2026 07:52 UTC
- Capturada
- 29/10/2026 08:09 UTC
- Huella del texto
faba298041a5d40c· 1006 palabras- Cambios detectados
- 0
- Copia de archivo
- Wayback Machine ↗